Profitelligence Profitelligence · Filing Ledger Open CI research →

Form 8-K · Current Report · Filed 2024-02-15

The Cigna Group Announces $3.2 Billion Accelerated Stock Repurchase

On February 14, 2024, The Cigna Group entered into accelerated share repurchase agreements with Deutsche Bank AG and Bank of America, N.A.

Filer
The Cigna Group CI · NYSE
Filed
Accession
0000950159-24-000100
CIK
0001739940
Signal
Medium impactHealthcare

Details

for the repurchase of $3.2 billion of its common stock. The repurchase is part of the company's existing share repurchase program, with an initial delivery of approximately 7.6 million shares on February 15, 2024. The final number of shares repurchased will be determined by the volume-weighted average price of Cigna's common stock over the term of the agreements, less a discount. Final settlement is expected in the second quarter of 2024.

Items reported

Item 8.01

Other Events

Share Repurchase Program Announced
Item 9.01

Financial Statements and Exhibits

Exhibits Furnished

Market reaction

Close before filing

$338.61

Next session

+0.7%

Since filing

-17.6%

Latest close

$279.05

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from CI reporting the same item, with the next session's move:

Exhibits (1)

About The Cigna Group

The Cigna Group is a leading global health services organization. Ranging across a comprehensive spectrum of health and wellness services, the company aims to improve the health, well-being, and peace of mind of those it serves. Notably, Cigna offers medical, dental, disability, life, and accident insurance coverage to individuals and businesses, extending its reach from individual clients to multinational corporations. Its primary business comprehends a vast network within the managed care sector, focusing on providing accessible and affordable healthcare solutions to its users. Cigna’s influence spans multiple sectors including health insurance, pharmacy benefit management, and behavioral health, highlighting its diverse portfolio. The company plays a crucial role in the health insurance market, consistently driving innovation in healthcare solutions and cost management. Its ability to integrate health services and provide holistic care solutions is pivotal in addressing the evolving needs of the healthcare landscape globally."}

Exchange NYSE Industry Healthcare Plans Company website ↗

Never miss another CI filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts